A key innovation of the framework is the introduction of a “lead financier” model, where one institution takes primary responsibility for procurement and safeguards on a given project.

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

GNRC Hospitals successfully organised its Spring CME 2026 — Clinical Neurophysiology Update at the NEDFi Convention Centre on Friday evening, bringing together leading neurologists, neurosurgeons and ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

On Wednesday, April 29, 2026, the Misty Copeland Foundation (MCF) will host its Spring Benefit at The Pool + The Grill in New ...